scholarly journals Novel Influenza H1N1 in Pregnancy: Report of a Diagnosed Case in Bangladesh

1970 ◽  
Vol 24 (2) ◽  
pp. 75-78
Author(s):  
Maliha Rashid ◽  
Rawshan Ara ◽  
Nasrin Akhter
Keyword(s):  
H1n1 Influenza ◽  
Interesting Case ◽  
Swine Flu ◽  
Adequate Treatment ◽  
Life Threatening ◽  
2009 H1n1 ◽  
Pandemic Flu ◽  
Antiviral Medications ◽  
Influenza H1n1 ◽  
In Pregnancy

Category C pandemic flu 2009 {H1N1 influenza), the disease that has reached pandemic proportions, holds everyone at risk today H1N1 influenza and pregnancy together, poses a greater risk for pregnant women and this deserves special attention. A swine flu pregnancy can be life threatening for both the mother and the baby. During the current pandemic of H1N1 influenza, few cases of H1N1 have been reported in pregnancy cases. We report one interesting case of H1N1 influenza, which was the only confirmed case of H1N1 Flu who survived with pregnancy in Bangladesh. Widespread vaccination, when available, prompt diagnosis, and adequate treatment with antiviral medications when infection occurs can save the life of the mother and the baby. Keywords: Novel influenza H1N1; pregnancy Bangladesh J Obstet Gynaecol, 2009; Vol. 24(2) : 75-78   DOI: http://dx.doi.org/10.3329/bjog.v24i2.8533

scholarly journals Novel Influenza H1N1 in Pregnancy: A Report of Two Cases

2009 ◽  
Vol 2009 ◽  
pp. 1-3 ◽  
Author(s):  
Dmitry Fridman ◽  
Oumar Kuzbari ◽  
Howard Minkoff
Keyword(s):  
Distress Syndrome ◽  
Risk Group ◽  
H1n1 Influenza ◽  
High Risk Group ◽  
Single Institution ◽  
Adequate Treatment ◽  
Antiviral Medications ◽  
Prompt Diagnosis ◽  
Influenza H1n1 ◽  
In Pregnancy

Background. Pregnant women are a high-risk group for morbidity and mortality from influenza. During the current pandemic of H1N1 influenza, few cases of H1N1 have been reported in pregnancy.Cases. We report two cases of H1N1 influenza which occurred in single institution in the course of one month. The first patient developed acute respiratory distress syndrome, required intubation, and eventually died. The second patient had influenza H1N1 that did not have any major sequela.Conclusion. H1N1 influenza in pregnancy can be associated with severe complications. Widespread vaccination, when available, prompt diagnosis, and adequate treatment with antiviral medications when infection occurs are required.

Perinatal transmission of dengue infection in a preterm neonate: a case report

2019 ◽  
Vol 49 (3) ◽  
pp. 239-240
Author(s):  
Jenisha Jain ◽  
Lakshmi V ◽  
Shanmughsundaram R
Keyword(s):  
At Risk ◽  
Case Report ◽  
Vertical Transmission ◽  
Preterm Neonate ◽  
Dengue Infection ◽  
Perinatal Transmission ◽  
Interesting Case ◽  
Life Threatening ◽  
In Pregnancy

Dengue infection during pregnancy carries the risk of vertical transmission to the fetus and newborn. This is higher if the infection occurs late in pregnancy and the mother delivers at the height of viremia. In such a scenario, both mother and neonate are at risk of life-threatening complications. We present an interesting case of dengue infection in a preterm neonate managed at our unit.

Nonventilatory strategies for patients with life-threatening 2009 H1N1 influenza and severe respiratory failure

2010 ◽  
Vol 38 ◽  
pp. e74-e90 ◽  
Author(s):  
Lena M. Napolitano ◽  
Pauline K. Park ◽  
Krishnan Raghavendran ◽  
Robert H. Bartlett
Keyword(s):  
Respiratory Failure ◽  
H1n1 Influenza ◽  
Severe Respiratory Failure ◽  
Life Threatening ◽  
2009 H1n1

2009 H1N1 influenza in pregnancy and reproductive-age women: a North East London experience

2010 ◽  
Vol 95 (Supplement 1) ◽  
pp. Fa50-Fa50
Author(s):  
O. Barigye ◽  
M. Noble ◽  
J. Sidhu ◽  
C. Otigbah ◽  
R. Howard
Keyword(s):  
H1n1 Influenza ◽  
Reproductive Age ◽  
North East ◽  
Reproductive Age Women ◽  
2009 H1n1 ◽  
In Pregnancy

scholarly journals Vaccination against swine flu caused narcolepsy in several european countries

2020 ◽  
pp. 182-187
Author(s):  
I. Boström ◽  
◽  
O. Lindberger ◽  
M. Partinen ◽  
A.M. Landtblom ◽  
...  
Keyword(s):  
Influenza A ◽  
Strong Association ◽  
Diagnostic Delay ◽  
Sleep Onset ◽  
H1n1 Influenza ◽  
European Countries ◽  
Swine Flu ◽  
Increased Risk ◽  
2009 H1n1

Narcolepsy is a rare sleeping disorder that gives sleep onset rapid eye movement periods and excessive daytime sleepiness. It is divided into two subgroups, narcolepsy type 1 where there also is orexin deficiency and cataplexy and narcolepsy type 2 that lack these features. Narcolepsy type 1 is assumed to be an autoimmune disease with destruction of orexinproducing cells. The pathology behind is unclear. There is a strong association to a class II HLA allele, HLADQB1*06:02 and the H1N1-virus and streptococcal infections has also been associated with narcolepsy. The severity of narcolepsy differs between patients from those who can manage their disease without medication to those who has a severe impact on their everyday life. There is a diagnostic delay between the onset of symptoms and time for diagnosis that in some cases can be more than a decade. The global mean prevalence is 30 per 100 000 inhabitants. The incidence in children in northern Europe has risen since 2010. An early study of the 2009 H1N1 influenza A pandemic indicated a high mortality and prompted efforts to rapidly come up with a vaccine. One of these was Pandemrix that was the most widely used in Europe and 61 % of the inhabitants in Sweden was vaccinated. Studies have shown an increased incidence of narcolepsy type 1 in European countries that had used Pandemrix, but no increased risk was seen in countries that had used other vaccines than Pandemrix.

scholarly journals Vaccination against swine flu caused narcolepsy in several european countries

2020 ◽  
pp. 182-187
Author(s):  
I. Boström ◽  
◽  
O. Lindberger ◽  
M. Partinen ◽  
A.M. Landtblom ◽  
...  
Keyword(s):  
Influenza A ◽  
Strong Association ◽  
Diagnostic Delay ◽  
Sleep Onset ◽  
H1n1 Influenza ◽  
European Countries ◽  
Swine Flu ◽  
Increased Risk ◽  
2009 H1n1

Narcolepsy is a rare sleeping disorder that gives sleep onset rapid eye movement periods and excessive daytime sleepiness. It is divided into two subgroups, narcolepsy type 1 where there also is orexin deficiency and cataplexy and narcolepsy type 2 that lack these features. Narcolepsy type 1 is assumed to be an autoimmune disease with destruction of orexinproducing cells. The pathology behind is unclear. There is a strong association to a class II HLA allele, HLADQB1*06:02 and the H1N1-virus and streptococcal infections has also been associated with narcolepsy. The severity of narcolepsy differs between patients from those who can manage their disease without medication to those who has a severe impact on their everyday life. There is a diagnostic delay between the onset of symptoms and time for diagnosis that in some cases can be more than a decade. The global mean prevalence is 30 per 100 000 inhabitants. The incidence in children in northern Europe has risen since 2010. An early study of the 2009 H1N1 influenza A pandemic indicated a high mortality and prompted efforts to rapidly come up with a vaccine. One of these was Pandemrix that was the most widely used in Europe and 61 % of the inhabitants in Sweden was vaccinated. Studies have shown an increased incidence of narcolepsy type 1 in European countries that had used Pandemrix, but no increased risk was seen in countries that had used other vaccines than Pandemrix.

Tobacco smoking and influenza (review)

MedAlliance ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 90-92
Keyword(s):  
Risk Factors ◽  
Influenza Infection ◽  
H1n1 Pandemic ◽  
Influenza Epidemic ◽  
Risk Of Death ◽  
Stop Smoking ◽  
2009 H1n1 ◽  
Former Smokers ◽  
The Russian Federation ◽  
Pandemic Flu

The review analyzed data on the risks of influenza infection and severe course in tobacco smokers compared with non-smokers. The incidence of influenza in the Russian Federation in 2018 amounted to 26.33 per 100 000 people, and was 24% lower than the incidence in 2017 (34.86 per 100 000) due to the fact that in recent years the coverage of the population with preventive vaccinations has been significantly increased against the flu. Meta-analyzes shows that current smokers are more likely to get the flu than non-smokers. It is noted that smoking may increase the risk of hospitalization in smokers (OR 1.32–2.18 in various meta-analyzes) and former smokers after infection with the influenza virus. Tobacco has been found to increase the risk of death from influenza among older people. At the same time, there is a study of risk factors for severe outcomes in patients hospitalized with the 2009 H1N1 pandemic flu, in which smoking was not a risk factor for severe outcomes. During the influenza epidemic, smokers and former smokers should be given the flu shot and be informed of the risk of hospitalization, and they are also strongly advised to stop smoking.

Sign in / Sign up

Export Citation Format

Share Document